Abstract: A query syntax analysis and postprocessing system and method receives a query request specifying values of a data type directed to a database without native support for the queried data type. A query engine or process for receiving a query request defined by a query syntax traverses the query request for a specification of an unsupported value or expression. In a large, distributed database environment, the query request may implicate multiple physical data stores, each having specific formats and recognized syntax. Values of unsupported or non-native types, or expressions that evaluate to an unsupported or non-native type, are identified and replaced with an expression that is recognized by the legacy database.

Abstract: A query syntax analysis and postprocessing system and method receives a query request specifying values of a data type directed to a database without native support for the queried data type. A query engine or process for receiving a query request defined by a query syntax traverses the query request for a specification of an unsupported value or expression. In a large, distributed database environment, the query request may implicate multiple physical data stores, each having specific formats and recognized syntax. Values of unsupported or non-native types, or expressions that evaluate to an unsupported or non-native type, are identified and replaced with an expression that is recognized by the legacy database.

Abstract: Techniques are presented for efficiently provisioning application-agnostic resource access to a variety of applications without modification to the native access control mechanisms of the applications and without transmission of a user's credentials over the network. A user of an application is authenticated by an authorization provider. An access token for the authenticated user is generated. A session password is generated based at least in part on the access token. The session password is applied by the user to the native access control mechanism of an application to facilitate access to resources (e.g., set of subject data) by the application. The resource access is achieved without modification to the native access control mechanism of the application and without transmission of the credentials (e.g., username, password, etc.) of the user over the network.

Abstract: Techniques are described herein for leveraging information about a user to enable a personal assistant module to make various inferences about what actions that may be responsive to a user declaration. In various implementations, upon identifying a user declaration received at a computing device, a plurality of candidate responsive actions that can be initiated by the computing device in response to the user declaration may be identified. A single candidate responsive action may then be non-deterministically (e.g., randomly, stochastically) selected to be exclusively initiated on the computing device in response to the user declaration.

Abstract: Techniques are described herein for leveraging information about a user to enable a personal assistant module to make various inferences about what actions that may be responsive to a user declaration. In various implementations, upon identifying a user declaration received at a computing device, a plurality of candidate responsive actions that can be initiated by the computing device in response to the user declaration may be identified. A single candidate responsive action may then be non-deterministically (e.g., randomly, stochastically) selected to be exclusively initiated on the computing device in response to the user declaration.

Abstract: Techniques are presented for efficiently provisioning application-agnostic resource access to a variety of applications without modification to the native access control mechanisms of the applications and without transmission of a user's credentials over the network. A user of an application is authenticated by an authorization provider. An access token for the authenticated user is generated. A session password is generated based at least in part on the access token. The session password is applied by the user to the native access control mechanism of an application to facilitate access to resources (e.g., set of subject data) by the application. The resource access is achieved without modification to the native access control mechanism of the application and without transmission of the credentials (e.g., username, password, etc.) of the user over the network.

Abstract: Techniques are described herein for leveraging information about a user to enable a personal assistant module to make various inferences about what actions that may be responsive to a user declaration. In various implementations, upon identifying a user declaration received at a computing device, a plurality of candidate responsive actions that can be initiated by the computing device in response to the user declaration may be identified. A single candidate responsive action may then be non-deterministically (e.g., randomly, stochastically) selected to be exclusively initiated on the computing device in response to the user declaration.

Abstract: The present invention provides agents having antimicrobial activity for preventing and treating infectious diseases. Thus, the present invention provides novel substituted piperidino phenyloxazolidinone derivatives, processes for making compounds as well as antimicrobial compositions containing said derivatives as active ingredients and methods of treating bacterial infections with the said derivatives.

Abstract: The present invention provides agents having antimicrobial activity for preventing and treating infectious diseases. Thus, the present invention provides novel substituted piperidino phenyloxazolidinone derivatives, processes for making compounds as well as antimicrobial compositions containing said derivatives as active ingredients and methods of treating bacterial infections with the said derivatives.

Abstract: The present invention provides agents having antimicrobial activity for preventing and treating infectious diseases. Thus, the present invention provides novel substituted piperidino phenyloxazolidinone derivatives, processes for making compounds as well as antimicrobial compositions containing said derivatives as active ingredients and methods of treating bacterial infections with the said derivatives.

Abstract: The present invention provides agents having high antimicrobial activity for preventing and treating infectious diseases. Thus, the present invention provides novel cyano-(substituted)-methylenepiperidinophenyl oxazolidinone derivatives, processes for making the compounds, as well as antimicrobial compositions containing said derivatives as active ingredients and methods of treating bacterial infections with the said derivatives.

Abstract: The present invention relates to optically pure S-(?)-benzoquinolizine carboxylic acids, their derivatives, salts, pseudopolymorphs, polymorphs and hydrates thereof, substantially free of their R-(+)-isomers, to processes for preparation of the optically pure S-(?)-benzoquinolizine carboxylic acids, their derivatives, salts, pseudopolymorphs, polymorphs and hydrates thereof substantially free of their R-(+)-isomers, and to pharmaceutical compositions comprising the S(?)-benzoquinolizine carboxylic acids, their derivatives, salts, pseudopolymorphs, polymorphs and hydrates thereof.

Abstract: The present invention relates to optically pure S-(?)-benzoquinolizine carboxylic acids, their derivatives, salts, pseudopolymorphs, polymorphs and hydrates thereof, substantially free of their R-(+)-isomers, to processes for preparation of the optically pure S-(?)-benzoquinolizine carboxylic acids, their derivatives, salts, pseudopolymorphs, polymorphs and hydrates thereof substantially free of their R-(+)-isomers, and to pharmaceutical compositions comprising the S(?)-benzoquinolizine carboxylic acids, their derivatives, salts, pseudopolymorphs, polymorphs and hydrates thereof.

Abstract: This invention relates to new generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, to their optical isomers, diastereomers or enantiomers, as well as pharmaceutically acceptable salts, hydrates, prodrugs, polymorphs and pseudopolymorphs thereof, to their preparation, to their compositions and to their use.

Abstract: The present invention provides agents having antimicrobial activity for preventing and treating infectious diseases. Thus, the present invention provides novel substituted piperidino phenyloxazolidinone derivatives, processes for making compounds as well as antimicrobial compositions containing said derivatives as active ingredients and methods of treating bacterial infections with the said derivatives.

Abstract: The present invention provides agents having high antimicrobial activity for preventing and treating infectious diseases. Thus, the present invention provides novel cyanoalkylpiperidinophenyl oxazolidinone derivatives having antimicrobial activity, favourable pharmacokinetic and safety profiles, processes for making the compounds, as well as antimicrobial compositions containing said derivatives as active ingredients and methods of treating microbial infections with the said derivatives.

Abstract: The present invention relates to a pharmaceutical composition in aqueous solution form useful for parenteral application to a subject for treatment or prevention of infective disease. In particular the present invention relates to such a composition having as an active agent S-(−)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid, S-(−)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid 0.2 hydrate or S-(−)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid arginine salt or a benzoquinolizine-2-carboxylic acid antibiotic drug. The field of the invention also includes processes for the preparation of such a composition, the use of such a composition in preparation of a medicament, and to the therapeutic or prophylactic use of such a composition.

Abstract: The invention relates to the new arginine salt forms of S-(−)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid, a process for their preparation and pharmaceutical formulations which comprise those arginine salt forms as the active ingredient for its use in treating antimicrobial infections.

Abstract: The present invention relates to optically pure S-(−)-benzoquinolizine carboxylic acids, their derivatives, salts, pseudopolymorphs, polymorphs and hydrates thereof, substantially free of their R-(+)-isomers, to processes for preparation of the optically pure S-(−)-benzoquinolizine carboxylic acids, their derivatives, salts, pseudopolymorphs, polymorphs and hydrates thereof substantially free of their R-(+)-isomers, and to pharmaceutical compositions comprising the S(−)-benzoquinolizine carboxylic acids, their derivatives, salts, pseudopolymorphs, polymorphs and hydrates thereof.

Abstract: The present invention provides agents having high antimicrobial activity for preventing and treating infectious diseases. Thus, the present invention provides novel cyano-(substituted)-methylenepiperidinophenyl oxazolidinone derivatives, processes for making the compounds, as well as antimicrobial compositions containing said derivatives as active ingredients and methods of treating bacterial infections with the said derivatives.